Sabra Health Care REIT, Inc.

Sabra Health Care REIT, Inc. (SBRA) Market Cap

Sabra Health Care REIT, Inc. has a market capitalization of .

No quote data available.

CEO: Richard K. Matros

Sector: Real Estate

Industry: REIT - Healthcare Facilities

IPO Date: 2002-04-02

Website: https://www.sabrahealth.com

Sabra Health Care REIT, Inc. (SBRA) - Company Information

Market Cap: -|Sector: Real Estate

Company Profile

As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing - Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.

Analyst Sentiment

67%
Buy

From 13 Active Polls

1Y Forecast: $21.80

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$21

Median

$22

High Bound

$22

Average

$22

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$21.80
▲ +18.09% Upside
Low Target
$21.00
14% Risk
Median Target
$22.00
19% Mid
High Target
$22.00
19% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 SABRA HEALTH CARE REIT INC (SBRA) — Investment Overview

🧩 Business Model Overview

SABRA HEALTH CARE REIT INC (SBRA) is a healthcare-focused real estate investment trust that owns and operates a portfolio of skilled nursing and related senior-care facilities through long-term, lease-backed arrangements with operating partners. The economic flow is straightforward: SBRA provides real estate capital and facilities management infrastructure, while licensed operators run day-to-day care delivery. This structure ties SBRA’s returns primarily to lease rent economics and facility-level performance, rather than to treatment-specific reimbursement volatility.

The model’s “stickiness” comes from the fact that care settings are regulated, facility build-outs are capital-intensive, and licensed operators typically seek long-duration stability to support staffing, compliance, and payer relationships. For SBRA, long lease duration and recurring rent collections create an income profile that is sensitive to tenant credit and occupancy, but less dependent on one-off transactions.

💰 Revenue Streams & Monetisation Model

Revenue is dominated by recurring rent under contractual lease agreements, with the majority of cash flows linked to the reliability of tenant payments and the operational health of the underlying facilities (occupancy, staffing levels, and service mix). Depending on lease terms, portions of expenses (or reimbursements) may be passed through, which can reduce SBRA’s direct exposure to cost inflation relative to a fully owned operating model.

Key margin drivers typically include:

  • Lease rent stability: cash collections and rent escalators, where applicable.
  • Operating partner performance: occupancy and payer mix affect the tenant’s ability to meet lease obligations.
  • Cost pass-through mechanics: the degree to which property-level operating expenses are recoverable under lease structure.

Because SBRA is a REIT, the monetisation lens is less about product margins and more about durability of cash rent, rent coverage by tenants, and the ability to re-lease or refinance assets across market cycles.

🧠 Competitive Advantages & Market Positioning

SBRA’s moat is best characterized as a combination of regulatory/hard-to-replicate facility ecosystem and credit underwriting and lease structuring. Skilled nursing and related care environments require specialized licensing, operational capability, and compliance with payer and regulatory requirements—factors that make rapid competitive scaling difficult. On top of this, SBRA’s returns depend on selecting and structuring leases with operators capable of maintaining service delivery and meeting payment obligations.

Why the moat is “hard”:

  • High barriers to entry (regulatory + operational): a competitor cannot easily replicate a similar portfolio without operator relationships, compliance capability, and capital for facility ownership.
  • Credit culture and underwriting: the ability to anticipate operator stress, structure leases to reflect risk, and manage property-level performance is difficult to copy quickly.
  • Integrated ecosystem: stable asset ownership paired with operational expertise (through relationships with established providers) supports lower default risk versus a “pure landlord” approach.

Competitive benchmarking (primary peers):

  • Omega Healthcare Investors (OHI): also concentrated in skilled nursing; similar tenant-credit sensitivity, but OHI’s operator mix and facility exposure differ.
  • Welltower (WELL): broader senior housing and healthcare real estate exposure; less concentrated in skilled nursing-only economics.
  • Healthpeak Properties (PEAK): focus includes medical office and senior living components; different reimbursement and demand drivers than SBRA’s skilled-care orientation.

Compared with these rivals, SBRA’s positioning is characterized by a tighter alignment to skilled nursing and allied facility economics, placing a premium on tenant selection, lease structuring, and the ability to manage occupancy and operator performance through cycles.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, SBRA’s growth and value creation should be evaluated through demand durability, portfolio resilience, and incremental deployment of capital into facilities with improving fundamentals.

  • Demographic demand for skilled care: aging populations and rising chronic-care needs support long-run utilization of post-acute and skilled services.
  • Facility modernization and throughput improvement: capital redeployment into renovations, productivity initiatives, and operating enhancements can improve occupancy and stabilize cash flows.
  • Operator consolidation dynamics: as smaller operators exit or merge, stronger operators may gain share, which can support lease performance if underwriting remains disciplined.
  • Continuum-of-care complexity: healthcare facility networks and regulatory obligations create friction for new entrants, supporting relative stability for established asset owners with proven operating partners.

⚠ Risk Factors to Monitor

  • Tenant credit risk: lease performance is directly linked to operator health. Deterioration in occupancy, labor costs, or reimbursement can translate into impaired rent coverage and higher default risk.
  • Reimbursement and regulatory pressure: changes to Medicaid and Medicare policy, documentation rules, and reimbursement methodologies can affect operator margins and, in turn, lease sustainability.
  • Interest rate and capital market access: REITs rely on ongoing refinancing and disciplined capital allocation; adverse funding conditions can constrain growth or increase the cost of capital.
  • Concentration risk: geographic and operator concentration can magnify shocks from local labor markets, payer mix, or compliance issues.
  • Property-level obsolescence: if facilities fail to meet evolving care delivery standards, re-tenanting and rent renewal dynamics can weaken.

📊 Valuation & Market View

Markets typically value healthcare REITs using REIT-oriented metrics rather than classic operating-company multiples. The key valuation framework often centers on cash flow durability (commonly framed via AFFO/FFO), dividend sustainability, and cap rate dynamics for real estate cash flows.

Drivers that move investor valuation generally include:

  • Rent collection reliability and evidence of resilient rent coverage.
  • Same-facility performance (occupancy trends, pricing under lease terms, and expense pass-through).
  • Credit spread and refinancing environment, which can influence the implied cost of equity and debt.
  • Portfolio quality: operator concentration, facility age, and the probability-weighted path to stable re-leasing.

In this sector, valuation tends to re-rate when cash flow visibility improves (or deteriorates) and when refinancing and credit conditions shift for tenant-heavy healthcare real estate.

🔍 Investment Takeaway

SBRA’s long-term investment case rests on owning healthcare facilities within a heavily regulated, operationally complex environment where rapid replication is difficult. The principal structural advantage is the combination of lease-based recurring income with disciplined credit underwriting and an ecosystem of operating partners, supported by durable end-demand for skilled care. The core debate centers on tenant-credit resilience and reimbursement/regulatory sensitivity; the long-run equity profile favors investors who underwrite cash flow durability, operator survivability, and disciplined capital allocation through cycles.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"SBRA reported Q1’26 revenue of $221.8M and net income of $40.0M (EPS $N/M due to data). Revenue rose 4.7% QoQ (from $211.9M in Q4’25) and 20.8% YoY (from $183.5M in Q1’25). Net income increased 46.8% QoQ (from $27.2M) and 0.2% YoY (from $40.3M), indicating earnings largely lagged revenue growth this quarter. Profitability: net margin improved to 18.0% in Q1’26 from 12.8% in Q4’25, but is slightly below Q1’25 (21.0%). Operating income was 0 in the provided dataset for Q1’26, so margin read-through is based on net income and pre-tax margins. Cash flow & capital returns: operating cash flow was $98.4M, and free cash flow was $98.4M. The company paid dividends of $75.7M during the quarter; the cash flow statement shows no buybacks. Dividend yield is ~1.6% (per provided ratios), implying shareholder returns are meaningfully tied to price performance. Balance sheet & resilience: total assets were $5.59B, up 1.8% QoQ. Equity was stable at ~$2.79B. Leverage increased as total debt rose to $1.26B (vs $2.55B in Q4’25 reported), but overall debt-to-equity remains the key watch item. Total shareholder returns: shares at $20.68 are up 13.8% over 1 year—positive momentum, though below a 20% threshold."

Revenue Growth

Good

Revenue grew 4.7% QoQ (211.9M to 221.8M) and 20.8% YoY (183.5M to 221.8M), with a clear upward YoY trajectory.

Profitability

Positive

Net income jumped 46.8% QoQ (27.2M to 40.0M) but was flat YoY (+0.2%, 40.3M to 40.0M). Net margin expanded QoQ (12.8% to 18.0%) but is down vs Q1’25 (21.0%).

Cash Flow Quality

Good

Strong cash generation: operating cash flow $98.4M and FCF $98.4M in Q1’26. Dividends of $75.7M were paid; payout ratio data suggests coverage is stretched but cash flow remains positive.

Leverage & Balance Sheet

Positive

Assets increased QoQ (+1.8%) and equity was broadly stable (~$2.79B). Debt levels appear volatile across quarters in the dataset, so leverage risk should be monitored, but balance-sheet size/resilience is intact.

Shareholder Returns

Positive

Price appreciation is solid but not extreme: +13.8% 1Y. Dividend yield is ~1.6%, so total return is supported, though there were no buybacks shown in Q1 cash flow.

Analyst Sentiment & Valuation

Positive

Consensus target around $21.2 vs $20.68 current implies modest upside (~2–3%). With positive recent performance (+7.99% YTD), sentiment is likely supportive but valuation looks not deeply discounted.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

SBRA’s Q1 2026 read-through is operationally strong but guidance discipline remains conservative until SHOP NOI visibility increases in Q2. Managed senior housing delivered sequential revenue +7.2% and cash NOI +9.5% with +60 bps margin expansion, while same-store occupancy rose +280 bps to 88.4% and cash NOI grew +14.4% on expense-per-occupied-room up only +1.8%. Management highlighted near-full Canada occupancy at 93.4% and continued SHOP margin gains, with Q1 SHOP same-store NOI growth landing at 14% versus a low- to mid-teens full-year guide. Capital deployment is aggressive: ~$206M invested YTD (estimated initial cash yield ~8%) plus $400M closed/awarded; another $690M managed senior housing and $94M skilled nursing are in the awarded pipeline (most SNF expected in Q2). The key swing factor is SHOP NOI execution versus range; management also emphasized AI/automation as a scalability lever rather than a near-term financial adjustment.

AI IconGrowth Catalysts

  • Managed senior housing sequential growth: revenue +7.2% and cash NOI +9.5% with margin expansion of 60 bps
  • Same-store managed senior housing occupancy +280 bps to 88.4% YoY; RevPAR +4.6% YoY and expense per occupied room +1.8% enabling cash NOI +14.4% YoY
  • Continued SHOP margin growth and improving same-store SHOP NOI growth (YoY higher than prior two quarters)
  • Corporate scalability push: AI/automation to streamline back-office workflows and operator-facing data/insights (aimed at faster decisioning and platform scalability)

Business Development

  • Closed/awarded managed senior housing + skilled nursing investments of $400 million YTD (management expects to materially exceed February total investments)
  • Award pipeline includes $690 million managed senior housing and $94 million awarded skilled nursing investments expected to close in Q2 (most of the $94 million)
  • CommuniCare transaction: disposed three Maryland skilled nursing facilities leased to CommuniCare for gross proceeds of $79.4 million (6.8% lease yield); management said this is a unique seller-exit dynamic (CommuniCare wants to exit Maryland)
  • Off-market deal sourcing: skilled nursing pipeline cited as 100% off-market via existing relationships; senior opportunities described as ~20% off-market and mostly marketed (by volume)
  • Landmark behavioral assets: management working with parties in court for exit; Landmark assets sold to a buyer group and Landmark team buying some assets; additional similar sales expected before the Q2 call

AI IconFinancial Highlights

  • Normalized FFO per share $0.38 and normalized AFFO per share $0.39 in Q1 2026 (FFO +9% YoY; AFFO +5% YoY)
  • Absolute normalized FFO/AFFO: $96.1 million / $100.6 million
  • Managed senior housing: sequential revenue +7.2%, cash NOI +9.5%, margin expansion +60 bps
  • Same-store managed senior housing: occupancy +280 bps to 88.4%; Canadian occupancy +270 bps to 93.4%; RevPAR +4.6% (+6.5% Canada); cash NOI +14.4% YoY
  • Expense per occupied room +1.8% YoY (operating leverage supporting cash NOI growth)
  • Investment activity: $102 million invested in Q1 (3 properties: 1 skilled nursing + preferred equity in senior housing development); $14.1 million additional post-close; YTD investments ~ $206 million with estimated initial cash yield of 8%
  • Additional awarded investments: $107 million managed senior housing and $94 million awarded skilled nursing (most expected to close in Q2)
  • Triple-net cash NOI drivers: annual rent escalators and increased collections from certain cash-basis tenants
  • Net debt/adjusted EBITDA 5.04x at 03/31/2026 (in line with target; management exploring leverage reduction where it supports YoY earnings growth)
  • Cost of permanent debt 3.92%; weighted avg remaining term ~4 years; next material maturity 2028; no floating-rate debt in permanent capital stack (only revolver is floating)
  • Capital markets: issued $128 million on a forward basis at average $20.19/share (after commissions); $451 million outstanding under forward contracts at average $19.03/share (after commissions)
  • ATM liquidity: $1.2 billion total liquidity at 03/31/2026 including $117 million unrestricted cash, $645 million revolver availability, and forward contracts; $353 million additional capacity under ATM
  • Disposition yield: $79.4 million gross proceeds from three MD SNFs at 6.8% lease yield; classified held for sale as of 03/31/2026

AI IconCapital Funding

  • Forward ATM issuance in Q1: $128 million issued forward at avg $20.19/share (after commissions)
  • Outstanding forward contracts under ATM: $451 million at avg $19.03/share (after commissions)
  • Plan to fund awarded investments on a leverage-neutral basis using forward proceeds + CommuniCare sale proceeds while retaining dry powder
  • Liquidity at 03/31/2026: ~ $1.2 billion (unrestricted cash $117 million; revolver availability $645 million; forward contracts $451 million); additional ATM availability $353 million
  • Leverage: net debt/adjusted EBITDA 5.04x

AI IconStrategy & Ops

  • AI-enabled REIT intent: corporate AI initiatives to streamline/enhance corporate functions; facility-level clinical pilots including prop-tech solutions (medical records, fall detection)
  • Automation/data/AI roadmap aimed at faster decision-making, deeper portfolio/operator insights, and increased platform scalability
  • SHOP underwriting: closed Q1 deals include IL, AL, and memory care, weighted to AL and memory care; average property vintage ~14 years
  • Cap-rate pressure acknowledgment: market opportunities cited as low-7% range; value-add opportunities with initial yields in the 6s targeting higher IRRs
  • SHOP portfolio transition actions: management not disclosing specific NOI impacts for assets being sold; indicated selective retention/replacement after Holiday transitions (new operators ~1 year; some assets not wanted to retain)

AI IconMarket Outlook

  • Guidance reaffirmed for 2026; management will revisit guidance in Q2 due to current trends
  • Vikram Malhotra follow-up: guidance not updated; management notes Q1 annualized is around midpoint/slightly below midpoint; SHOP same-store NOI guided low- to mid-teens growth; achieved 14% in Q1
  • Dividend: board declared quarterly cash dividend $0.30/share payable 05/29/2026; record date 05/15/2026; dividend payout 77% of first-quarter normalized AFFO per share
  • SHOP outlook emphasis: management reiterates historical approach to not revisit in Q1 unless material change occurs

AI IconRisks & Headwinds

  • Cap-rate pressure for SHOP opportunities: most market volume cited at low-7% (implies underwriting spread compression versus prior periods)
  • Guidance conservatism: Q1 typically conservative; requires SHOP NOI trajectory confirmation as line of sight improves in Q2
  • Competitive skilled nursing environment: private buyers (OpCo + PropCo + ancillary businesses) can pay more; company cannot compete on SNF marketed deals
  • Occupancy ceiling effects: Canadian portfolio already near-full (93.4%); management expects mid-90s to include ups/downs rather than sustained rapid trajectory

Q&A: Analyst Interest

  • Guidance conservatism and what changes the range: Management said conservatism is typical for early-year (Q1), despite positive trends and investing yields. They reiterated they will reevaluate only in Q2. Primary driver remains SHOP NOI growth as pipeline firms up and visibility improves.
  • Pipeline execution probability and deal cadence: Analysts asked cadence and how much of the large $690M awarded funnel converts into closings. Management stated $200M awarded is expected to close with no doubt. For $690M, they noted no precedent for predictability, but expect a “fair number” and to materially exceed prior-year total investment.
  • SHOP exit velocity and portfolio transition/sales: Questioning focused on performance trajectory since Holiday transitions and potential effect of selling assets. Management said they are not disclosing numbers, but progression is improving; some assets will be excluded/managed due to changing operator outlook. For the three assets being sold, they would not disclose book value or expected proceeds at that time.

Sentiment: MIXED

Note: This summary was synthesized by AI from the SBRA Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — Sabra Health Care REIT, Inc. (SBRA) Financial Profile